Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Small hydrophobic protein (SH protein) is a short, single-pass transmembrane protein encoded by viruses in the Paramyxoviridae and Pneumoviridae families, most notably Human Respiratory Syncytial Virus (hRSV) and Mumps virus. It functions as a viroporin, forming pentameric homooligomers that act as ion channels to modulate host cell membrane permeability and disrupt cellular ion homeostasis. Beyond its channel activity, the SH protein plays a significant role in viral pathogenesis by inhibiting host cell apoptosis and suppressing innate immune responses, such as TNF-alpha signaling and NLRP3 inflammasome activation. Although the protein is often non-essential for viral replication in cell culture, its absence leads to marked viral attenuation in animal models, highlighting its importance as a critical virulence factor. Consequently, the SH protein is considered a promising therapeutic target for the development of novel antiviral drugs aimed at treating severe respiratory infections and other viral diseases.
Ion channel inhibition and viroporin blockade
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small hydrophobic protein (SH protein) (SH).